Ingvorsen, Camilla
Novo Nordisk (Denmark)
3 papers on CoChatORCID 0000-0002-4369-8328
Most cited papers
- Verified
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways
Rakipovski, G., Rolin, B., Nøhr, J., Klewe, I., Frederiksen, K. S., Augustin, R., Hecksher-Sørensen, J., Ingvorsen, C., Polex-Wolf, J., & Knudsen, L. B. (2018) · JACC: Basic to Translational Science
Diabetes Treatment and ManagementAtherosclerosis and Cardiovascular Diseases
Cited by 509
- Verified
Chronic obstructive pulmonary disease and asthma‐associated Proteobacteria, but not commensal Prevotella spp., promote Toll‐like receptor 2‐independent lung inflammation and pathology
Larsen, J. M., Musavian, H. S., Butt, T. M., Ingvorsen, C., Thysen, A. H., & Brix, S. (2015) · Immunology
Chronic Obstructive Pulmonary Disease (COPD) ResearchImmune Response and Inflammation
Cited by 200
- Verified
Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes
An, D., Chiu, A., Flanders, J. A., Song, W., Shou, D., Lu, Y.-C., Grunnet, L. G., Winkel, L., Ingvorsen, C., Christophersen, N. S., et al. (2018) · Proceedings of the National Academy of Sciences
Pancreatic function and diabetesTissue Engineering and Regenerative Medicine
Cited by 200
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free